Blog

Video Marketing Strategy for Diabetes & Cardiometabolic Health

by Jason Shafton

In diabetes and cardiometabolic health, video is the quickest way to build the trust this category requires – a real clinician on camera can do more than a page of copy ever could. But medical claims, consent, and compliance turn health video into a minefield, and most brands either create sterile corporate reels or risk a takedown. We develop the video strategy that builds trust, remains compliant, and drives patients.

The Challenge

One claim spoken on camera can lead to ad rejection or regulatory exposure

Video makes medical claims feel more authoritative and more permanent, which is exactly why platforms and regulators scrutinize health video hard. A clinician who says the wrong thing about lowering blood sugar or reversing disease can get an ad rejected, a channel flagged, or worse. Most video teams either over-sanitize until the content is lifeless or wing it without a claims framework. The strategy has to make trust vivid while keeping every spoken word inside the compliance lines.

Patient stories are simultaneously your greatest asset and your biggest liability

Real people managing diabetes or heart disease on camera build trust like nothing else, but they also carry consent, privacy, and testimonial-compliance risk that most brands underestimate. Done wrong, a patient testimonial becomes a regulatory problem or an ethics failure. Done right, with proper consent and framing, it is the most persuasive asset you have. The difference is a disciplined process for sourcing, consenting, and reviewing patient video that most health companies never build.

Corporate health video is polished, costly, and completely overlooked

Many cardiometabolic companies invest in glossy brand films that look like pharma ads and get almost no engagement, because the audience does not trust production value – they trust authenticity and clinical substance. High spend on the wrong format produces beautiful assets nobody watches to the end. In this category, a credible clinician explaining something useful on a phone camera routinely outperforms a five-figure produced spot. Getting the format right matters more than getting the budget high.

Video without a distribution or measurement plan is a cost center, not a channel

Brands routinely produce video and then post it and hope, with no plan for which platform, which cut, or how success is measured. A long explainer that works on YouTube dies on TikTok, and a clip optimized for reach may reach no one with actual clinical intent. Without a distribution and measurement plan tied to patient acquisition, video becomes an expensive content graveyard. Production is the cheap part – distribution and intent are where the return is won or lost.

How We Can Help

We begin by determining what video is actually meant to do in your funnel. Trust-building explainers, patient stories, and clinician-led education each have a distinct role, and we map which formats move a cardiometabolic patient toward signup instead of creating assets that simply fill a channel. This keeps production centered on video with a clear purpose, rather than video made because a competitor created one.

Next, we develop the compliance and consent framework this category demands. We collaborate with your clinical and regulatory teams to establish what can be said on camera, then create a disciplined process for sourcing, consenting, and reviewing patient stories so your most powerful asset never turns into a liability. This framework allows the team to produce quickly without risking a takedown or an ethics issue.

Then we select formats designed for trust rather than gloss. We prioritize credible clinician-led and patient-led formats that feel authentic to a skeptical audience, producing them at a pace a lean team can maintain instead of wagering the budget on one costly brand film. In this category, believable outperforms beautiful, and a repeatable format system beats one-off productions.

For distribution, we pair each format with the platform and audience where it can genuinely connect – long-form education on YouTube, short vertical clips for social discovery, and embedded video on the pages where patients make decisions. We create the distribution plan before production, ensuring every asset has a destination and a purpose instead of being posted and forgotten.

For measurement, we monitor watch-through on clinical content, qualified video-sourced traffic, and video-driven signups and consult bookings – not view counts. We assess whether the right people keep watching to the point that matters and whether their attention converts. Views are diagnostic at best; patients remain the goal.

What sets us apart is that we operate video as an embedded growth function connected to patient acquisition and rooted in your genuine clinical authority, rather than acting as a production house that sells assets. Succeeding with video in a skeptical, regulated category takes someone who understands both the craft and the compliance realities, and that is exactly where we work.

What we deliver

In cardiometabolic health, a credible clinician using a phone camera to explain one useful thing will out-convert a five-figure brand film every time. The audience is not purchasing production value – they are deciding if they trust a human, and trust is not delivered in 4K.

Our Methodology

We provide video marketing through a 90-day sprint designed to establish an ongoing program. The first 30 days focus on strategy and guardrails: we determine video's role in your funnel, select the formats, and create the claims-and-consent framework with your clinical and regulatory team. Days 30 through 60 establish the production system: we create the first trust-first assets, set the review-and-publish cadence, and develop a distribution plan for each platform. Days 60 through 90 focus on operation and measurement: we run production and distribution live while instrumenting video-sourced signups and consult bookings.

Unlike a production house, we connect video to patient acquisition and integrate compliance into the workflow instead of adding it after the shoot. In a regulated category, consent and claims processes must come before production, not afterward. We build on the clinical authority already within your company, prioritize authentic formats over expensive polish, and evaluate the program by patients driven rather than views accumulated.

The Insights You Want

Right in your inbox. We’ve done the work, and now we’re sharing it with you. Sign up to stay in the loop.

Get The Latest Updates


Enter your email address

Our Approach

The first 30 days establish strategy and guardrails. We determine what video needs to accomplish in your funnel, select the formats, and create the claims-and-consent framework with your clinical and regulatory leads. You receive a clear assessment of why your current video is or is not converting and which formats merit production.

Days 30 through 60 establish the production system. We create the first trust-first assets with your clinicians and, when appropriate, consented patients, set up the compliance review step, and develop the distribution plan for each platform. From your team, we need a clinical reviewer, access to on-camera experts and a patient-story pipeline, plus any existing brand assets.

Days 60 through 90 shift into live operation and measurement. We run production and distribution while instrumenting video-sourced traffic, watch-through on clinical content, and signups and consult bookings against your baseline. Since video compounds and production continues, most engagements extend beyond the first sprint, with a typical initial build lasting three to six months.

Our cadence includes a weekly working session with your content and clinical leads, along with async performance updates. We work within your existing content and product rhythm so video supports the rest of the funnel rather than functioning as a separate asset factory.

If your diabetes & cardiometabolic health company needs video marketing strategy leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

What does video marketing cost for a diabetes and cardiometabolic health company?

We price video engagements at a fixed monthly fee based on production volume, format mix, and the compliance overhead required by your category. We intentionally direct budget toward authentic, repeatable formats rather than one expensive brand film, which typically delivers a better return for the same spend. Because video compounds over time, most relationships extend beyond the initial sprint into an ongoing program.

How soon will we see results from a video marketing engagement?

The strategy, compliance framework, and initial assets are established during the first 90 days, and early trust indicators such as strong watch-through on clinical content generally emerge within that period. Video-sourced signups and consult bookings develop more gradually as your library expands and distribution compounds. Trust accumulates over time in a skeptical health category, so we set expectations around that curve instead of promising an instant spike.

How does the video marketing team work with our existing staff?

We integrate with your content, clinical, and regulatory teams instead of working as an external production house. We require a clinical reviewer for compliance, access to on-camera experts and a patient-story pipeline, and your brand assets. We hold a weekly working session with your content lead and manage the production and distribution cadence within your existing workflow.

How is Winston Francois different from a traditional video production agency?

A production agency delivers polished assets and then moves on. We operate video as an embedded growth function, incorporate compliance and consent into the workflow so a health brand never risks a takedown, and connect every asset to patient acquisition rather than view counts. We prioritize authentic clinician-led and patient-led formats over expensive polish because those are what truly build trust in this category.

How is ROI measured for a video marketing engagement?

We measure watch-through on clinical content, qualified video-sourced traffic, and video-driven signups and consult bookings, all compared with your pre-engagement baseline. We exclude raw view counts because they obscure whether the right people are watching and converting. The scorecard focuses on turning video attention into patients, not generating vanity reach.

What kind of diabetes and cardiometabolic health company is a good fit for this service?

This service is suited to companies roughly in the 5M to 100M ARR range that have credible clinical experts prepared to appear on camera and the patience to develop a compounding video library. It works best if you can provide a clinical reviewer and access to experts and patient stories. If there is no credible person to feature on camera, other channels may deserve priority first. We begin with a strategy call and a review of your existing video and channels.


Related Solutions

Solutions

Top Articles

Frank Growth – Episode 238 – The Best Kept Secret Sport with Ozge Erturk

Tuesday, September 22, 2026

Frank Growth – Episode 238 – The Best Kept Secret Sport with Ozge Erturk

Episode #238: Ozge Erturk – Hitting #1 in the App Store on zero paid media FloSports is profitable, covers 25+ sports, and has a million subscribers. Its CMO explains how that math works. For subscription operators, growth leads, and anyone marketing to an audience the mainstream ignores. Ozge Erturk is the CMO of FloSports, a...
Frank Growth – Episode 237 – Stop Buying Users Who Leave with Michelle Matthews

Tuesday, September 15, 2026

Frank Growth – Episode 237 – Stop Buying Users Who Leave with Michelle Matthews

Episode #237: Michelle Matthews – Acquisition is the easy part in health and wellness This episode is about the gap between what marketing promises and what the product delivers, and what that gap actually costs a company. For growth leaders, founders, and product teams building for people who show up on a bad day. Michelle...
Frank Growth – Episode 236 – Turn Marketers Into AI Strategists with Elyssa Steiner

Tuesday, September 8, 2026

Frank Growth – Episode 236 – Turn Marketers Into AI Strategists with Elyssa Steiner

Episode #236: Elyssa Steiner – Rebuilding a 21-person marketing team in 30 days Marketing is not a lead factory. It is a growth system, and the operating model is the ceiling on what ships. For CMOs and marketing leaders who inherited a team built for a smaller company. Elyssa Steiner is Chief Marketing Officer at...
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy

Tuesday, June 16, 2026

Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy

Episode #224: Alex Roy — Bootstrapping an AI company for 12 years, no funding He founded an AI company in 2014—when AI was a punchline—bootstrapped it with zero outside capital, and landed Fortune 50 clients. For founders and growth operators figuring out how to build (and sell) AI products in a market that shifts every...

See more

Browse Categories

See more

Ready to unlock your growth?

Book Free Call

We take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.